Home›Companies›Biotech & Pharma›Invectys

Invectys, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 10, 2024·Suggest an edit

About Invectys

Invectys is a private company based in Houston, Texas, incorporated in 2020 in Delaware. It has reported $4,000,000 raised in two offerings on Form D since July 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 30, 2024Oct 10, 2024$4,000,000fully sold6$666KDebt, Options, Securities on exercise, Convertible Promissory Notes and Warrants.Rule 506(b)Form D ↗
Not yetJul 15, 2021$00—Convertible NotesRule 506(b)Form D ↗
Total, two offerings$4,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Invectys's Form D filed Oct 10, 2024.

RW
Rosemary Williams
Executive officer
DG
David Guyer
Director
JK
Jake Kushner
Executive officer and director
IE
Ivor Elfiri
Director

Earlier filings also listed Praveen Tyle (president and ceo, director, last listed Jul 2021) and Cary McNair (director, last listed Jul 2021).

Sources

  1. SECInvectys, Inc. filing history